neoplasm
• 12% of mice exhibit fibroadenoma in the mammary gland
|
• 30% of mice develop osseous metaplasia
|
• in 12% in mice
|
• 18% of mice develop carcinoma in situ in the kidney
|
• 30% of mice develop stromal sarcoma
|
• 6% of mice develop neurofibrosarcoma
|
• in 6% of mice
|
• 6% of mice exhibit odontoma
|
• 30% of mice develop osseous metaplasia
(J:63264)
• 6% of mice exhibit odontoma
(J:63264)
• 35% of mice develop schwannomas
(J:92413)
|
• 6% of mice develop osteoma
|
skeleton
• 12% of mice exhibit odontoblastic hyperplasia
|
• in 6% of mice
|
• 6% of mice develop osteoma
|
• osteogenic hyperplasia in 47% of mice
|
nervous system
• 82% of mice exhibit Schwann cell hyperplasia
|
• 6% of mice develop neurofibrosarcoma
|
• 30% of mice develop osseous metaplasia
(J:63264)
• 6% of mice exhibit odontoma
(J:63264)
• 35% of mice develop schwannomas
(J:92413)
|
renal/urinary system
• 18% of mice develop carcinoma in situ in the kidney
|
• 53% of mice exhibit renal tubular cell hyperplasia
|
vision/eye
craniofacial
• 12% of mice exhibit odontoblastic hyperplasia
|
growth/size/body
• 12% of mice exhibit odontoblastic hyperplasia
|
respiratory system
• in 12% in mice
|
integument
• 12% of mice exhibit fibroadenoma in the mammary gland
|
endocrine/exocrine glands
• 12% of mice exhibit fibroadenoma in the mammary gland
|
cellular
• 82% of mice exhibit Schwann cell hyperplasia
|